We demonstrated that CFP1 partial knock-out significantly inhibited (A2780) or delayed (ES-2) the clone-forming ability of ovarian cancer cells (Fig. 2D) and reduced cell proliferation (Fig. 2E). Here, CXXC1 is linked to ovarian cancer.